BBI Faculty Conversations: Dr. Manu Setty

The Brotman Baty Institute was recently joined by BBI Member Dr. Manu Setty, assistant professor in the Herbold Computational Biology Program at Fred Hutchinson Cancer Center. BBI: How did you get interested in your area of research? Dr. Setty: Going all the way back to high school, I had a passing interest in both molecular biology and computer science. In India…
Read More
A University of Washington program to support STEM students from low-income and underserved backgrounds is now nine years old. And it aims to spread the model to other institutions. The Washington State Academic RedShirt program (STARS) takes a cue from college sports, where “redshirting” enables an extra year of eligibility for athletes. Students sign up for an extra year at the UW,…
Read More
Organizer Dr. Fritz Roth and keynote speakers Drs. Clare Turnbull and Doug Fowler offer their observations and insights of the event and suggestions for the 2023 symposium to be held in the U.K. The fifth annual Mutual Scanning Symposium was held June 13, 14, and 16 in Toronto and online. Organizer Dr. Fritz Roth and keynote speakers Drs. Clare Turnbull…
Read More
Vascular dysfunction. Ice melt in Antarctica. Chronic liver disease. University of Washington graduate students are finding solutions to these problems — and many more — with the support of Washington Research Foundation. And thanks to the foundation’s most recent gift, emerging scientists at the UW and Washington State University will be supported for years to come. Washington Research Foundation (WRF)…
Read More
Kubota Vision, a clinical-stage ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings, announced today the completion of the Phase III clinical trial investigating emixustat hydrochloride (“emixustat”) in patients with macular atrophy secondary to Stargardt disease. The study was a multi-center, randomized, double-masked, and placebo-controlled Phase III clinical study in which subjects were randomly assigned to emixustat 10 mg or…
Read More
University of Washington researchers have developed the first adaptive socket, giving people with limb amputation a new level of freedom: “I can focus on my life.” Many people might take for granted that they can run, play with their kids or pets, and move about without much thought. People with limb amputation, though, struggle with the comfort, fit and function…
Read More
A Seattle DNA analysis startup is taking on a project with global ambitions with $5.5 million in new funds from the Bill & Melinda Gates Foundation and the U.S. National Institutes of Health. Phase Genomics will catalog the diversity of viruses that infect bacteria in samples from the human gut and wastewater. The team will determine which viruses infect which bacteria…
Read More
Seattle-area health data company Truveta announced a partnership Tuesday with biopharma giant Pfizer, which will use Truveta’s platform to monitor the safety of its COVID vaccines and therapies across the U.S. Truveta has access to de-identified data from 20 health systems, representing more than 15% of U.S. healthcare. The company also released data from a recent analysis of COVID-19, suggesting…
Read More
Florence Chardon’s introduction to scientific concepts started when she was old enough to understand dinnertime conversations with her parents and two older sisters. Her mother and father, both European physicists, would hold court usually on one of two topics: science or world politics. Listening to Chardon, a Ph.D. candidate in the UW Medicine Department of Genome Sciences, it is evident…
Read More